ACTIV.A.C.? THERAPY SYSTEM WNDACT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,health professional report with the FDA on 2020-03-26 for ACTIV.A.C.? THERAPY SYSTEM WNDACT manufactured by Kinetic Concepts, Inc..

Event Text Entries

[188495635] Additional device information for v. A. C.? Granufoam? Dressing lot number 7239966v009: expiration date: 31-oct-2022. Unique identifier (udi) #: (b)(4). Device manufacture date: 08-nov-2019. Based on information provided, it cannot be determined that the alleged maceration is related to the activ. A. C.? Therapy system. Device labeling, available in print and online, states: never leave a v. A. C. ? Dressing in place without active v. A. C. ? Therapy for more than 2 hours. If therapy is off for more than 2 hours, remove the old dressing and irrigate the wound. Either apply a new v. A. C.? Dressing from an unopened sterile package and restart v. A. C.? Therapy; or apply an alternative dressing at the direction of the treating clinician. Ensuring dressing integrity it is recommended that a clinician or patient (in the home) visually check the dressing every two hours to ensure that the foam is firm and collapsed in the wound bed while therapy is active, if not: if you find that the seal is broken and the v. A. C.? Drape has become loose, trim away any loose or moist edges, ensure the skin is dry and then apply new drape strips. Note: if a leak source is identified, patch with additional drape to ensure seal integrity.
Patient Sequence No: 1, Text Type: N, H10


[188495636] On 25-feb-2020, the following information was reported to kci by the patient: the patient allegedly experienced technical issues with the activ. A. C.? Therapy system and the wound was saturated upon removal of the v. A. C.? Granufoam? Dressing. On 26-feb-2020, the following information was reported to kci by the nurse: the patient allegedly developed maceration that required debridement to resolve the issue. The patient was subsequently placed back on v. A. C.? Therapy. On (b)(6) 2020, the device was tested per quality control procedure by kci service center, and the unit passed the quality control checks and met specifications. On (b)(6) 2020, the device was placed with the patient. On (b)(6) 2020, the device was tested per quality control procedure by kci quality engineering and the unit passed the quality control checks and met specifications. Inspection and testing of the device did not reveal any evidence of an operational malfunction with the unit. On 18-mar-2020, a device history review was performed for v. A. C.? Granufoam? Dressing lot number 7239966v009. All end release testing of the product and packaging met specifications.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3009897021-2020-00128
MDR Report Key9886988
Report SourceCONSUMER,HEALTH PROFESSIONAL
Date Received2020-03-26
Date of Report2020-03-26
Date of Event2020-02-25
Date Mfgr Received2020-02-25
Device Manufacturer Date2007-11-16
Date Added to Maude2020-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. STEVEN JACKSON
Manufacturer Street6203 FARINON DRIVE
Manufacturer CitySAN ANTONIO, TX
Manufacturer CountryUS
Manufacturer Phone2556438
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACTIV.A.C.? THERAPY SYSTEM
Generic NameOMP
Product CodeOMP
Date Received2020-03-26
Returned To Mfg2020-02-25
Model NumberWNDACT
Lot Number7239966V009
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerKINETIC CONCEPTS, INC.
Manufacturer Address6203 FARINON DRIVE SAN ANTONIO, TX US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.